Skip to main content
Erschienen in: Clinical Oral Investigations 4/2012

01.08.2012 | Original Article

Four-year results following treatment of intrabony periodontal defects with an enamel matrix derivative alone or combined with a biphasic calcium phosphate

verfasst von: Malgorzata Pietruska, Jan Pietruski, Katalin Nagy, Michel Brecx, Nicole Birgit Arweiler, Anton Sculean

Erschienen in: Clinical Oral Investigations | Ausgabe 4/2012

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study was to evaluate the 4-year clinical outcomes following regenerative surgery in intrabony defects with either EMD + BCP or EMD. Twenty-four patients with advanced chronic periodontitis, displaying one-, two-, or three-walled intrabony defect with a probing depth of at least 6 mm, were randomly treated with either EMD + BCP (test) or EMD alone (control). The following clinical parameters were evaluated at baseline, at 1 year and at 4 years after regenerative surgery: plaque index, gingival index, bleeding on probing, probing depth, gingival recession, and clinical attachment level (CAL). The primary outcome variable was CAL. No differences in any of the investigated parameters were observed at baseline between the two groups. The test group demonstrated a mean CAL change from from 10.8 ± 1.6 mm to 7.4 ± 1.6 mm (p < 0.001) and to 7.6 ± 1.7 mm (p < 0.001) at 1 and 4 years, respectively. In the control group, mean CAL changed from 10.4 ± 1.3 at baseline to 6.9 ± 1.0 mm (p < 0.001) at 1 year and 7.2 ± 1.2 mm (p < 0.001) at 4 years. At 4 years, two defects in the test group and three defects in the control group have lost 1 mm of the CAL gained at 1 year. Compared to baseline, at 4 years, a CAL gain of ≥3 mm was measured in 67% of the defects (i.e., in 8 out of 12) in the test group and in 75% of the defects (i.e., in 9 out of 12) in the control group. There were no statistically significant differences in any of the investigated parameters at 1 and at 4 years between the two groups. Within their limits, the present results indicate that: (a) the clinical improvements obtained with both treatments can be maintained over a period of 4 years, and (b) in two- and three-walled intrabony defects, the addition of BCP did not additionally improve the outcomes obtained with EMD alone. In two- and three-walled intrabony defects, the combination of EMD + BCP did not show any advantage over the use of EMD alone.
Literatur
1.
Zurück zum Zitat Wikesjö UME, Selvig KA (1999) Periodontal wound healing and regeneration. Periodontol 2000 19:21–39PubMedCrossRef Wikesjö UME, Selvig KA (1999) Periodontal wound healing and regeneration. Periodontol 2000 19:21–39PubMedCrossRef
2.
Zurück zum Zitat Hammarström L, Heijl L, Gestrelius S (1997) Periodontal regeneration in a buccal dehiscence model in monkeys after application of enamel matrix proteins. J Clin Periodontol 24:669–677PubMedCrossRef Hammarström L, Heijl L, Gestrelius S (1997) Periodontal regeneration in a buccal dehiscence model in monkeys after application of enamel matrix proteins. J Clin Periodontol 24:669–677PubMedCrossRef
3.
Zurück zum Zitat Sculean A, Donos N, Brecx M, Reich E, Karring T (2000) Treatment of intrabony defects with enamel matrix proteins and guided tissue regeneration. An experimental study in monkeys. J Clin Periodontol 27:466–472PubMedCrossRef Sculean A, Donos N, Brecx M, Reich E, Karring T (2000) Treatment of intrabony defects with enamel matrix proteins and guided tissue regeneration. An experimental study in monkeys. J Clin Periodontol 27:466–472PubMedCrossRef
4.
Zurück zum Zitat Gkranias ND, Graziani F, Sculean A, Donos N (2010) Wound healing following regenerative procedures in furcation degree III defects: histomorphometric outcomes. Clin Oral Investig. Oct 22 (in press) Gkranias ND, Graziani F, Sculean A, Donos N (2010) Wound healing following regenerative procedures in furcation degree III defects: histomorphometric outcomes. Clin Oral Investig. Oct 22 (in press)
5.
Zurück zum Zitat Heijl L (1997) Periodontal regeneration with enamel matrix derivative in one human experimental defect. A case report. J Clin Periodontol 24:693–696PubMedCrossRef Heijl L (1997) Periodontal regeneration with enamel matrix derivative in one human experimental defect. A case report. J Clin Periodontol 24:693–696PubMedCrossRef
6.
Zurück zum Zitat Sculean A, Donos N, Windisch P, Gera I, Brecx M, Reich E, Karring T (1999) Healing of human intrabony defects following treatment with enamel matrix proteins or guided tissue regeneration. J Periodontal Res 34:310–322PubMedCrossRef Sculean A, Donos N, Windisch P, Gera I, Brecx M, Reich E, Karring T (1999) Healing of human intrabony defects following treatment with enamel matrix proteins or guided tissue regeneration. J Periodontal Res 34:310–322PubMedCrossRef
7.
Zurück zum Zitat Sculean A, Chiantella GC, Windisch P, Donos N (2000) Clinical and histologic evaluation of treatment of intrabony defects with an enamel matrix protein derivative (Emdogain®). Int J Periodontics Restorative Dent 20:375–381 Sculean A, Chiantella GC, Windisch P, Donos N (2000) Clinical and histologic evaluation of treatment of intrabony defects with an enamel matrix protein derivative (Emdogain®). Int J Periodontics Restorative Dent 20:375–381
8.
Zurück zum Zitat Yukna RA, Mellonig J (2000) Histologic evaluation of periodontal healing in humans following regenerative therapy with enamel matrix derivative. A 10-case series. J Periodontol 71:752–759PubMedCrossRef Yukna RA, Mellonig J (2000) Histologic evaluation of periodontal healing in humans following regenerative therapy with enamel matrix derivative. A 10-case series. J Periodontol 71:752–759PubMedCrossRef
9.
Zurück zum Zitat Sculean A, Stavropoulos A, Berakdar M, Windisch P, Karring T, Brecx M (2005) Formation of human cementum following different modalities of regenerative therapy. Clin Oral Investig 9:58–64PubMedCrossRef Sculean A, Stavropoulos A, Berakdar M, Windisch P, Karring T, Brecx M (2005) Formation of human cementum following different modalities of regenerative therapy. Clin Oral Investig 9:58–64PubMedCrossRef
10.
Zurück zum Zitat Bosshardt DD, Sculean A, Windisch P, Pietursson BE, Lang NP (2005) Effects of enamel matrix proteins on tissue formation along the roots of human teeth. J Periodontal Res 40:158–167PubMedCrossRef Bosshardt DD, Sculean A, Windisch P, Pietursson BE, Lang NP (2005) Effects of enamel matrix proteins on tissue formation along the roots of human teeth. J Periodontal Res 40:158–167PubMedCrossRef
11.
Zurück zum Zitat Mazjoub Z, Bobbo M, Atiyeh F, Cordioli G (2005) Two patterns of histologic healing in an intrabony defect following treatment with an enamel matrix derivative: a human case report. Int J Periodontics Restorative Dent 25:283–294 Mazjoub Z, Bobbo M, Atiyeh F, Cordioli G (2005) Two patterns of histologic healing in an intrabony defect following treatment with an enamel matrix derivative: a human case report. Int J Periodontics Restorative Dent 25:283–294
12.
Zurück zum Zitat Heijl L, Heden G, Svardström G, Östgren A (1997) Enamel matrix derivative (Emdogain®) in the treatment of intrabony periodontal defects. J Clin Periodontol 24:705–714PubMedCrossRef Heijl L, Heden G, Svardström G, Östgren A (1997) Enamel matrix derivative (Emdogain®) in the treatment of intrabony periodontal defects. J Clin Periodontol 24:705–714PubMedCrossRef
13.
Zurück zum Zitat Pontoriero R, Wennström J, Lindhe J (1999) The use of barrier membranes and enamel matrix proteins in the treatment of angular bone defects. A prospective controlled clinical study. J Clin Periodontol 26:833–840PubMedCrossRef Pontoriero R, Wennström J, Lindhe J (1999) The use of barrier membranes and enamel matrix proteins in the treatment of angular bone defects. A prospective controlled clinical study. J Clin Periodontol 26:833–840PubMedCrossRef
14.
Zurück zum Zitat Froum SJ, Weinberg MA, Rosenberg E, Tarnow D (2001) A comparative study utilizing open flap debridement with and without enamel matrix derivative in the treatment of periodontal intrabony defects: a 12-month re-entry study. J Periodontol 72:25–34PubMedCrossRef Froum SJ, Weinberg MA, Rosenberg E, Tarnow D (2001) A comparative study utilizing open flap debridement with and without enamel matrix derivative in the treatment of periodontal intrabony defects: a 12-month re-entry study. J Periodontol 72:25–34PubMedCrossRef
15.
Zurück zum Zitat Sculean A, Windisch P, Chiantella GC, Donos N, Brecx M, Reich E (2001) Treatment of intrabony defects with enamel matrix proteins and guided tissue regeneration. A prospective controlled clinical study. J Clin Periodontol 28:397–403PubMedCrossRef Sculean A, Windisch P, Chiantella GC, Donos N, Brecx M, Reich E (2001) Treatment of intrabony defects with enamel matrix proteins and guided tissue regeneration. A prospective controlled clinical study. J Clin Periodontol 28:397–403PubMedCrossRef
16.
Zurück zum Zitat Tonetti MS, Lang NP, Cortellini P, Suvan JE, Adriaens P, Dubravec D, Fonzar A, Fourmousis I, Mayfield L, Rossi R, Silvestri M, Tiedemann C, Topoll H, Vangsted T, Wallkamm B (2002) Enamel matrix proteins in the regenerative therapy of deep intrabony defects. A multicentre randomized controlled clinical trial. J Clin Periodontol 29:317–325PubMedCrossRef Tonetti MS, Lang NP, Cortellini P, Suvan JE, Adriaens P, Dubravec D, Fonzar A, Fourmousis I, Mayfield L, Rossi R, Silvestri M, Tiedemann C, Topoll H, Vangsted T, Wallkamm B (2002) Enamel matrix proteins in the regenerative therapy of deep intrabony defects. A multicentre randomized controlled clinical trial. J Clin Periodontol 29:317–325PubMedCrossRef
17.
Zurück zum Zitat Guida L, Annunziata M, Belardo S, Farina R, Scabbia A, Trombelli L (2007) Effect of autogenous cortical bone particulate in conjunction with enamel matrix derivative in the treatment of periodontal intraosseous defects. J Periodontol 78:231–238PubMedCrossRef Guida L, Annunziata M, Belardo S, Farina R, Scabbia A, Trombelli L (2007) Effect of autogenous cortical bone particulate in conjunction with enamel matrix derivative in the treatment of periodontal intraosseous defects. J Periodontol 78:231–238PubMedCrossRef
18.
Zurück zum Zitat Gurinsky BS, Mills MP, Mellonig JT (2004) Clinical evaluation of demineralized freeze-dried bone allograft and enamel matrix derivative versus enamel matrix derivative alone for the treatment of periodontal osseous defects in humans. J Periodontol 75:1309–1318PubMedCrossRef Gurinsky BS, Mills MP, Mellonig JT (2004) Clinical evaluation of demineralized freeze-dried bone allograft and enamel matrix derivative versus enamel matrix derivative alone for the treatment of periodontal osseous defects in humans. J Periodontol 75:1309–1318PubMedCrossRef
19.
Zurück zum Zitat Aspriello SD, Ferrante L, Rubini C, Piemontese M (2011) Comparative study of DFDBA in combination with enamel matrix derivative versus DFDBA alone for treatment of periodontal intrabony defects at 12 months post-surgery. Clin Oral Invest 15:225–232CrossRef Aspriello SD, Ferrante L, Rubini C, Piemontese M (2011) Comparative study of DFDBA in combination with enamel matrix derivative versus DFDBA alone for treatment of periodontal intrabony defects at 12 months post-surgery. Clin Oral Invest 15:225–232CrossRef
20.
Zurück zum Zitat Yamamoto S, Masuda H, Shibukawa Y, Yamada S (2007) Combination of bovine-derived xenografts and enamel matrix derivative in the treatment of intrabony periodontal defects in dogs. Int J Periodontics Restorative Dent 27:471–479PubMed Yamamoto S, Masuda H, Shibukawa Y, Yamada S (2007) Combination of bovine-derived xenografts and enamel matrix derivative in the treatment of intrabony periodontal defects in dogs. Int J Periodontics Restorative Dent 27:471–479PubMed
21.
Zurück zum Zitat Sculean A, Windisch P, Keglevich T, Chiantella GC, Gera I, Donos N (2003) Clinical and histologic evaluation of human intrabony defects treated with an enamel matrix protein derivative combined with a bovine-derived xenograft. Int J Periodontics Restorative Dent 23:47–55PubMed Sculean A, Windisch P, Keglevich T, Chiantella GC, Gera I, Donos N (2003) Clinical and histologic evaluation of human intrabony defects treated with an enamel matrix protein derivative combined with a bovine-derived xenograft. Int J Periodontics Restorative Dent 23:47–55PubMed
22.
Zurück zum Zitat Lekovic V, Camargo PM, Weinlaender M, Nedic M, Aleksic Z, Kenney EB (2000) A comparison between enamel matrix proteins used alone or in combination with bovine porous bone mineral in the treatment of intrabony periodontal defects in humans. J Periodontol 71:1110–1116PubMedCrossRef Lekovic V, Camargo PM, Weinlaender M, Nedic M, Aleksic Z, Kenney EB (2000) A comparison between enamel matrix proteins used alone or in combination with bovine porous bone mineral in the treatment of intrabony periodontal defects in humans. J Periodontol 71:1110–1116PubMedCrossRef
23.
Zurück zum Zitat Velasquez-Plata D, Scheyer ET, Mellonig JT (2002) Clinical comparison of an enamel matrix derivative used alone or in combination with a bovine-derived xenograft for the treatment of periodontal osseous defects in humans. J Periodontol 73:433–440PubMedCrossRef Velasquez-Plata D, Scheyer ET, Mellonig JT (2002) Clinical comparison of an enamel matrix derivative used alone or in combination with a bovine-derived xenograft for the treatment of periodontal osseous defects in humans. J Periodontol 73:433–440PubMedCrossRef
24.
Zurück zum Zitat Zucchelli G, Amore C, Montebugnoli L, De Sanctis M (2003) Enamel matrix proteins and bovine porous mineral in the treatment of intrabony defects: a comparative controlled clinical trial. J Periodontol 74:1725–1735PubMedCrossRef Zucchelli G, Amore C, Montebugnoli L, De Sanctis M (2003) Enamel matrix proteins and bovine porous mineral in the treatment of intrabony defects: a comparative controlled clinical trial. J Periodontol 74:1725–1735PubMedCrossRef
25.
Zurück zum Zitat Kuru B, Yilmaz S, Argin K, Noyan U (2006) Enamel matrix derivative alone or in combination with a bioactive glass in wide intrabony defects. Clin Oral Invest 10:227–234CrossRef Kuru B, Yilmaz S, Argin K, Noyan U (2006) Enamel matrix derivative alone or in combination with a bioactive glass in wide intrabony defects. Clin Oral Invest 10:227–234CrossRef
26.
Zurück zum Zitat Sculean A, Pietruska M, Arweiler NB, Auschill TM, Nemcovsky C (2007) Four year results of a prospective controlled clinical study evaluating healing of intrabony defects following treatment with an enamel matrix protein derivative alone or combined with a bioactive glass. J Clin Periodontol 34:507–513PubMedCrossRef Sculean A, Pietruska M, Arweiler NB, Auschill TM, Nemcovsky C (2007) Four year results of a prospective controlled clinical study evaluating healing of intrabony defects following treatment with an enamel matrix protein derivative alone or combined with a bioactive glass. J Clin Periodontol 34:507–513PubMedCrossRef
27.
Zurück zum Zitat Bokan I, Bill JS, Schlagenhauf U (2006) Primary flap closure combined with Emdogain® alone or Emdogain® and Cerasorb® in the treatment of intra-bony defects. J Clin Periodontol 33:885–893PubMedCrossRef Bokan I, Bill JS, Schlagenhauf U (2006) Primary flap closure combined with Emdogain® alone or Emdogain® and Cerasorb® in the treatment of intra-bony defects. J Clin Periodontol 33:885–893PubMedCrossRef
28.
Zurück zum Zitat Nery EB, LeGeros RZ, Lynch KL, Lee K (1992) Tissue response to biphasic calcium phosphate ceramic with different ratios of HA/βTCP in periodontal osseous defects. J Periodontol 63:729–735PubMedCrossRef Nery EB, LeGeros RZ, Lynch KL, Lee K (1992) Tissue response to biphasic calcium phosphate ceramic with different ratios of HA/βTCP in periodontal osseous defects. J Periodontol 63:729–735PubMedCrossRef
29.
Zurück zum Zitat Jensen SS, Yeo A, Dard M, Hunziker E, Schenk R, Buser D (2007) Evaluation of a novel biphasic calcium phosphate in standardized bone defects. A histologic and histomorphometric study in the mandibles of minipigs. Clin Oral Implants Res 18:752–760PubMedCrossRef Jensen SS, Yeo A, Dard M, Hunziker E, Schenk R, Buser D (2007) Evaluation of a novel biphasic calcium phosphate in standardized bone defects. A histologic and histomorphometric study in the mandibles of minipigs. Clin Oral Implants Res 18:752–760PubMedCrossRef
30.
Zurück zum Zitat Stein JM, Fickl S, Yekta SS, Hoischen U, Ocklenburg C, Smeets R (2009) Clinical evaluation of a biphasic calcium composite grafting material in the treatment of human periodontal intrabony defects: a 12-month randomized controlled clinical trial. J Periodontol 80:1774–1782PubMedCrossRef Stein JM, Fickl S, Yekta SS, Hoischen U, Ocklenburg C, Smeets R (2009) Clinical evaluation of a biphasic calcium composite grafting material in the treatment of human periodontal intrabony defects: a 12-month randomized controlled clinical trial. J Periodontol 80:1774–1782PubMedCrossRef
31.
Zurück zum Zitat Jepsen S, Topoll H, Rengers H, Heinz B, Teich M, Hoffmann T, Al-Machot E, Meyle J, Jervøe-Storm PM (2008) Clinical outcomes after treatment of intra-bony defects with an EMD/synthetic bone graft or EMD alone: a multicentre randomized controlled clinical trial. J Clin Periodontol 35:420–428PubMedCrossRef Jepsen S, Topoll H, Rengers H, Heinz B, Teich M, Hoffmann T, Al-Machot E, Meyle J, Jervøe-Storm PM (2008) Clinical outcomes after treatment of intra-bony defects with an EMD/synthetic bone graft or EMD alone: a multicentre randomized controlled clinical trial. J Clin Periodontol 35:420–428PubMedCrossRef
32.
Zurück zum Zitat Meyle J, Hoffmann T, Topoll H, Heinz B, Al-Machot E, Jervøe-Storm P-M, Meiß C, Eickholz P, Jepsen S (2011) A multi-centre randomized controlled clinical trial on the treatment of intra-bony defects with enamel matrix derivatives/synthetic bone graft or enamel matrix derivatives alone: results after 12 months. J Clin Periodontol 38:652–660PubMedCrossRef Meyle J, Hoffmann T, Topoll H, Heinz B, Al-Machot E, Jervøe-Storm P-M, Meiß C, Eickholz P, Jepsen S (2011) A multi-centre randomized controlled clinical trial on the treatment of intra-bony defects with enamel matrix derivatives/synthetic bone graft or enamel matrix derivatives alone: results after 12 months. J Clin Periodontol 38:652–660PubMedCrossRef
33.
Zurück zum Zitat Armitage GC (1999) Development of a classification system for periodontal diseases and conditions. Ann Periodontol 4:1–6PubMedCrossRef Armitage GC (1999) Development of a classification system for periodontal diseases and conditions. Ann Periodontol 4:1–6PubMedCrossRef
34.
Zurück zum Zitat Löe H (1967) The gingival index, the plaque index and the retention index systems. J Periodontol 38:610–616PubMedCrossRef Löe H (1967) The gingival index, the plaque index and the retention index systems. J Periodontol 38:610–616PubMedCrossRef
35.
Zurück zum Zitat Blomlöf JPS, Blomlöf LB, Lindskog SF (1996) Smear removal and collagen exposure after non-surgical root planing followed by etching with EDTA gel preparation. J Periodontol 67:841–845PubMedCrossRef Blomlöf JPS, Blomlöf LB, Lindskog SF (1996) Smear removal and collagen exposure after non-surgical root planing followed by etching with EDTA gel preparation. J Periodontol 67:841–845PubMedCrossRef
36.
Zurück zum Zitat Gunsolley JC, Elswick RK, Davenport JM (1998) Equivalence and superiority testing in regeneration clinical trials. J Periodontol 69:521–527PubMedCrossRef Gunsolley JC, Elswick RK, Davenport JM (1998) Equivalence and superiority testing in regeneration clinical trials. J Periodontol 69:521–527PubMedCrossRef
37.
Zurück zum Zitat Kahldahl WB, Kalkwarf KL, Patil KD, Molvar MP, Dyer JK (1996) Long-term evalution of periodontal therapy: I. Respone to 4 therapeutic modalities. J Periodontol 67:93–102CrossRef Kahldahl WB, Kalkwarf KL, Patil KD, Molvar MP, Dyer JK (1996) Long-term evalution of periodontal therapy: I. Respone to 4 therapeutic modalities. J Periodontol 67:93–102CrossRef
38.
Zurück zum Zitat Tonetti MS, Pini Prato G, Cortellini P (1996) Factors affecting the healing response of intrabony defects following guided tissue regeneration and access flap surgery. J Clin Periodontol 23:548–556PubMedCrossRef Tonetti MS, Pini Prato G, Cortellini P (1996) Factors affecting the healing response of intrabony defects following guided tissue regeneration and access flap surgery. J Clin Periodontol 23:548–556PubMedCrossRef
39.
Zurück zum Zitat Sculean A, Nikolidakis D, Schwarz F (2008) Regeneration of periodontal tissues: combinations of barrier membranes and grafting materials—biological foundation and preclinical evidence. A systematic review. J Clin Periodontol 35(suppl 8):106–116PubMedCrossRef Sculean A, Nikolidakis D, Schwarz F (2008) Regeneration of periodontal tissues: combinations of barrier membranes and grafting materials—biological foundation and preclinical evidence. A systematic review. J Clin Periodontol 35(suppl 8):106–116PubMedCrossRef
40.
Zurück zum Zitat Iorio-Siciliano V, Andreuccetti G, Siciliano AI, Blasi A, Sculean A, Salvi GE (2011) Clinical outcome following treatment of non-contained intrabony defects with enamel matrix derivative (EMD) or guided tissue regeneration (GTR). A 12-month randomized controlled clinical trial. J Periodontol 82:62–71CrossRef Iorio-Siciliano V, Andreuccetti G, Siciliano AI, Blasi A, Sculean A, Salvi GE (2011) Clinical outcome following treatment of non-contained intrabony defects with enamel matrix derivative (EMD) or guided tissue regeneration (GTR). A 12-month randomized controlled clinical trial. J Periodontol 82:62–71CrossRef
41.
Zurück zum Zitat Tonetti MS, Pini-Prato G, Cortellini P (1995) Effect of cigarette smoking on periodontal healing following GTR in infrabony defects. A preliminary retrospective study. J Clin Periodontol 22:229–234PubMedCrossRef Tonetti MS, Pini-Prato G, Cortellini P (1995) Effect of cigarette smoking on periodontal healing following GTR in infrabony defects. A preliminary retrospective study. J Clin Periodontol 22:229–234PubMedCrossRef
42.
Zurück zum Zitat Sculean A, Windisch P, Szendröi-Kiss D, Horváth A, Rosta P, Becker J, Gera I, Schwarz F (2008) Clinical and histologic evaluation of an enamel matrix derivative combined with a biphasic calcium phosphate for the treatment of human intrabony periodontal defects. J Periodontol 79:1991–1999PubMedCrossRef Sculean A, Windisch P, Szendröi-Kiss D, Horváth A, Rosta P, Becker J, Gera I, Schwarz F (2008) Clinical and histologic evaluation of an enamel matrix derivative combined with a biphasic calcium phosphate for the treatment of human intrabony periodontal defects. J Periodontol 79:1991–1999PubMedCrossRef
Metadaten
Titel
Four-year results following treatment of intrabony periodontal defects with an enamel matrix derivative alone or combined with a biphasic calcium phosphate
verfasst von
Malgorzata Pietruska
Jan Pietruski
Katalin Nagy
Michel Brecx
Nicole Birgit Arweiler
Anton Sculean
Publikationsdatum
01.08.2012
Verlag
Springer-Verlag
Erschienen in
Clinical Oral Investigations / Ausgabe 4/2012
Print ISSN: 1432-6981
Elektronische ISSN: 1436-3771
DOI
https://doi.org/10.1007/s00784-011-0611-2

Weitere Artikel der Ausgabe 4/2012

Clinical Oral Investigations 4/2012 Zur Ausgabe

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Update Zahnmedizin

Bestellen Sie unseren kostenlosen Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.